Structured Summary
Abstract
A cytokine with both pro- and anti-inflammatory actions that depend upon the cellular microenvironment. Oncostatin M is a 28 kDa monomeric glycoprotein that is similar in structure to LEUKEMIA INHIBITORY FACTOR. Its name derives from the the observation that it inhibited the growth of tumor cells and augmented the growth of normal fibroblasts.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Aspects Covered
30 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2007(1987)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Oncostatin M. Medical Subject Headings (MeSH). 2026. Unique ID D053683. http://id.nlm.nih.gov/mesh/2026/D053683
- Oncostatin M. In: Wikipedia. https://en.wikipedia.org/wiki/Oncostatin_M
- Oncostatin M. In: Wikidata. https://www.wikidata.org/wiki/Q909425